IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection

Mucosal Immunology

Volumn 6, Issue 1, 2013, Pages 69-82

  Kumar, P ^a   Thakar, M S ^a,b   Ouyang, W ^c   Malarkannan, S ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; EPITHELIUM CELL; INFECTION RESISTANCE; INFLAMMATION; INFLUENZA; LUNG LAVAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPLEEN; WILD TYPE;

EID: 84867658823     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.49     Document Type: Article

References (58)

1. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001). (Pubitemid 32204059)
2. Achdout, H. et al. Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol. 171, 915-923 (2003). (Pubitemid 36871405)
3. Gill, J. R. et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch. Pathol. Lab. Med. 134, 235-243 (2010).
4. Capelozzi, V. L. et al. Pathological and ultrastructural analysis of surgical lung biopsies in patients with swine-origin influenza type A/H1N1 and acute respiratory failure. Clinics (Sao Paulo) 65, 1229-1237 (2010).
5. Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H. D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101, 4620-4624 (2004). (Pubitemid 38437460)
6. Pekosz, A., Newby, C., Bose, P. S. & Lutz, A. Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology 386, 61-67 (2009).
7. Kash, J. C. et al. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. MBio. 2 (2011).
8. Harder, J. et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J. Respir. Cell Mol. Biol. 22, 714-721 (2000). (Pubitemid 30400251)
9. de Paiva, C. S. et al. Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. J. Inflamm. (Lond) 6, 31 (2009).
10. Colgan, S. P. et al. IL-4 directly modulates function of a model human intestinal epithelium. J. Immunol. 153, 2122-2129 (1994). (Pubitemid 24256683)
11. Barasch, J. et al. Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell 99, 377-386 (1999).
12. Vermeer, P. D., Harson, R., Einwalter, L. A., Moninger, T. & Zabner, J. Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J. Respir. Cell Mol. Biol. 28, 286-295 (2003). (Pubitemid 36238005)
13. Deutscher, N. et al. Functional expression of the interleukin-11 receptor alpha-chain in normal colonic epithelium and colon cancer. Int. J. Colorectal Dis. 21, 573-581 (2006). (Pubitemid 44111287)
14. Kiessling, S. et al. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. J. Biol. Chem. 279, 10304-10315 (2004). (Pubitemid 38372637)
15. Morimoto, M. et al. Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J. Immunol. 176, 491-495 (2006). (Pubitemid 43023295)
16. Wolk, K. & Sabat, R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17, 367-380 (2006). (Pubitemid 44572879)
17. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008). (Pubitemid 351347912)
18. Eyerich, S. et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest 119, 3573-3585 (2009).
19. Crellin, N. K., Trifari, S., Kaplan, C. D., Cupedo, T. & Spits, H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281-290 (2010).
20. Simonian, P. L. et al. gammadelta T cells protect against lung fibrosis via IL-22. J. Exp. Med. 207, 2239-2253 (2010).
21. Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
22. Satoh-Takayama, N. et al. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J. Immunol. 183, 6579-6587 (2009).
23. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
24. Sanos, S. L. et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83-91 (2009).
25. Satoh-Takayama, N. et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273-280 (2010).
26. Colonna, M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15-23 (2009).
27. Couceiro, J. N., Paulson, J. C. & Baum, L. G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155-165 (1993). (Pubitemid 23235070)
28. Seo, S. U. et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS. Pathog. 7, e1001304 (2011).
29. Kumar, P. et al. High-throughput detection method for influenza virus. JoVE (2012).
30. Dhiman, R. et al. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J. Immunol. 183, 6639-6645 (2009).
31. Satoh-Takayama, N. et al. Lymphotoxin-beta receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells. Eur. J. Immunol. 41, 780-786 (2011).
32. Scriba, T. J. et al. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180, 1962-1970 (2008).
33. Ma, S. D., Lancto, C. A., Enomoto, S., Abrahamsen, M. S. & Rutherford, M. S. Expression and regulation of IL-22 by bovine peripheral blood gamma/delta T cells. Gene 451, 6-14 (2010).
34. Yao, S. et al. Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis. PLoS. Pathog. 6, e1000789 (2010).
35. Ness-Schwickerath, K. J. & Morita, C. T. Regulation and function of IL-17A- and IL-22-producing gammadelta T cells. Cell Mol. Life Sci. 68, 2371-2390 (2011).
36. Huntington, N. D. et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206, 25-34 (2009).
37. Liu, C. C., Perussia, B. & Young, J. D. The emerging role of IL-15 in NK-cell development. Immunol. Today 21, 113-116 (2000). (Pubitemid 30122697)
38. Mount, A. M. & Belz, G. T. Mouse models of viral infection: influenza infection in the lung. Methods Mol. Biol. 595, 299-318 (2010).
39. Buchweitz, J. P., Harkema, J. R. & Kaminski, N. E. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 35, 424-435 (2007).
40. Sentman, C. L. et al. Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma 8, 605-614 (1989). (Pubitemid 20009178)
41. Luci, C. et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
42. Koka, R. et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J. Exp. Med. 197, 977-984 (2003). (Pubitemid 36523195)
43. Nakamura, R. et al. Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J. Virol. 84, 5574-5582 (2010).
44. Chow, K. P. et al. Enhanced IL-10 production by CD4+ T cells primed in IL-15Ralpha-deficient mice. Eur. J. Immunol. 41, 3146-3156 (2011).
45. Yokoyama, S., Takada, K., Hirasawa, M., Perera, L. P. & Hiroi, T. Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease. J. Clin. Immunol. 31, 1038-1044 (2011).
46. Kauffman, S. L. Cell proliferation in the mammalian lung. Int. Rev. Exp. Pathol. 22, 131-191 (1980). (Pubitemid 12152687)
47. Rock, J. R. et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. USA 106, 12771-12775 (2009).
48. Wolk, K., Kunz, S., Asadullah, K. & Sabat, R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168, 5397-5402 (2002). (Pubitemid 34556115)
49. Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
50. Weiss, L. M. et al. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum. Pathol. 18, 1155-1159 (1987). (Pubitemid 18000301)
51. Nakagome, K. et al. High expression of IL-22 suppresses antigeninduced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J. Immunol. 187, 5077-5089 (2011).
52. Guo, H. & Topham, D. J. Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 84, 7750-7759 (2010).
53. Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol 36, 1309-1323 (2006).
54. Fernandez-Sesma, A. et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295-6304 (2006). (Pubitemid 43927432)
55. Sanos, S. L. & Diefenbach, A. Isolation of NK cells and NK-like cells from the intestinal lamina propria. Methods Mol. Biol. 612, 505-517 (2010).
56. Guo, H., Samarakoon, A., Vanhaesebroeck, B. & Malarkannan, S. The p110 delta of PI3 K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J. Exp. Med. 205, 2419-2435 (2008).
57. Rajasekaran, K. et al. Transforming growth factor-\{beta\}-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production. J. Biol. Chem. 286, 31213-31224 (2011).
58. Awasthi, A. et al. Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. J. Exp. Med. 207, 1923-1938 (2010).